Published in Mech Dev on April 01, 2001
Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J (2006) 3.26
A Wnt survival guide: from flies to human disease. J Invest Dermatol (2009) 2.91
Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation. Nat Cell Biol (2013) 1.64
Tbx18 regulates the development of the ureteral mesenchyme. J Clin Invest (2006) 1.63
Wnt signalling in lung development and diseases. Respir Res (2006) 1.55
Molecular regulation of kidney development: is the answer blowing in the Wnt? Pediatr Nephrol (2007) 1.52
Cell and molecular biology of kidney development. Semin Nephrol (2009) 1.32
Down-regulation of the canonical Wnt β-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD. PLoS One (2011) 1.13
Wilms tumor--a renal stem cell malignancy? Pediatr Nephrol (2011) 1.11
Requirement of Wnt/beta-catenin signaling in pronephric kidney development. Mech Dev (2008) 1.09
Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun (2010) 1.07
Hox10 genes function in kidney development in the differentiation and integration of the cortical stroma. PLoS One (2011) 1.03
Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development. J Cell Physiol (2008) 0.95
Brachy-syndactyly caused by loss of Sfrp2 function. J Cell Physiol (2008) 0.94
Complex and dynamic patterns of Wnt pathway gene expression in the developing chick forebrain. Neural Dev (2009) 0.92
Xenopus frizzled-4S, a splicing variant of Xfz4 is a context-dependent activator and inhibitor of Wnt/beta-catenin signaling. Cell Commun Signal (2005) 0.90
The complex roles of Wnt antagonists in RCC. Nat Rev Urol (2011) 0.89
Increased expression of secreted frizzled-related protein 4 in polycystic kidneys. J Am Soc Nephrol (2008) 0.89
Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Müllerian duct. Mol Reprod Dev (2006) 0.82
Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem (2014) 0.79
AHR regulates WT1 genetic programming during murine nephrogenesis. Mol Med (2011) 0.77
Kidney Regeneration: Lessons from Development. Curr Pathobiol Rep (2015) 0.77
A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming. Environ Health Perspect (2011) 0.77
sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling. Am J Physiol Cell Physiol (2016) 0.76
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression. J Nephrol (2016) 0.75
Cellular heterogeneity in the ureteric progenitor niche and distinct profiles of branching morphogenesis in organ development. Development (2017) 0.75
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68
Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science (1989) 4.79
Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science (1991) 3.69
The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol Cell (2000) 2.47
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36
Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem (2001) 2.31
Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem (2000) 2.24
Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem (1994) 1.95
A screening method for isolating DNA repair-deficient mutants of CHO cells. Somatic Cell Genet (1980) 1.77
Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest (1993) 1.75
Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest (1995) 1.68
Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem (1990) 1.62
TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. Development (2001) 1.59
The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. Mol Cell Biol (2001) 1.55
Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (1991) 1.44
Unexpected overnight admissions following day-case surgery: an analysis of a dedicated ENT day care unit. Ann R Coll Surg Engl (2000) 1.43
Mucociliary clearance abnormalities in the HIV-infected patient: a precursor to acute sinusitis. Laryngoscope (1995) 1.42
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36
Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci U S A (1994) 1.31
Fluorescence in situ hybridization analysis of keratinocyte growth factor gene amplification and dispersion in evolution of great apes and humans. Proc Natl Acad Sci U S A (1997) 1.29
Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene (1992) 1.28
Molecular identification of a human DNA repair gene following DNA-mediated gene transfer. Nature (1984) 1.27
Frontoethmoidectomy in the treatment of mucoceles. A neglected operation. Arch Otolaryngol Head Neck Surg (1986) 1.25
Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med (1993) 1.24
Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc Natl Acad Sci U S A (1987) 1.21
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene (2006) 1.20
Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci (1991) 1.20
miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene (2010) 1.20
Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes. J Invest Dermatol (1993) 1.15
Cyclophosphamide hemorrhagic cystitis. J Urol (1966) 1.15
Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene (2011) 1.14
Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469. J Biol Chem (2000) 1.14
Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13
Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem (1996) 1.13
Isolation and partial sequence analysis of rat basic somatomedin. Endocrinology (1982) 1.12
Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol (1994) 1.11
Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein. Oncogene (1988) 1.11
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53. Oncogene (2008) 1.10
K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res (1991) 1.10
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem (1997) 1.09
Low-dose radiotherapy for multicystic benign lymphoepithelial lesions of the parotid gland in HIV-positive patients: long-term results. Head Neck (1995) 1.08
Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants. J Biol Chem (1993) 1.08
Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08
Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem (1996) 1.07
A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J Biol Chem (1993) 1.07
HGF/SF in angiogenesis. Ciba Found Symp (1997) 1.06
Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J Cell Biol (1994) 1.05
Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene (2012) 1.03
Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann N Y Acad Sci (1991) 1.01
Emergence of the keratinocyte growth factor multigene family during the great ape radiation. Proc Natl Acad Sci U S A (1992) 1.01
Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes (1996) 1.01
Comparative transplacental carcinogenesis by directly acting and metabolism-dependent alkylating agents in rodents and nonhuman primates. IARC Sci Publ (1989) 1.01
Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett (1992) 1.00
Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol (1996) 1.00
Ectopic thyroid tissue presenting as a midline neck mass. Int J Pediatr Otorhinolaryngol (1996) 1.00
K-ras activation in neoplasms of the human female reproductive tract. Cancer Res (1990) 0.99
Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J Invest Dermatol (1996) 0.99
A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. Endocrinology (1996) 0.99
Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture. Am J Physiol (1995) 0.98
Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem Suppl (1992) 0.98
Growth factor-regulated pathways in epithelial cell proliferation. Am Rev Respir Dis (1990) 0.98
Identification and dynamics of a heparin-binding site in hepatocyte growth factor. Biochemistry (1999) 0.96
Molecular cloning and chromosomal localization of DNA sequences associated with a human DNA repair gene. Mol Cell Biol (1985) 0.96
Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. Biochem J (1997) 0.96
Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors. Mol Pharmacol (1996) 0.96
Incidental paranasal sinus abnormalities on MRI of the brain. Clin Radiol (1991) 0.94
Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development (1996) 0.93
The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. Structure (1998) 0.92
Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl Med Biol (2004) 0.91
Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol (1995) 0.91
Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF. Biochem Biophys Res Commun (1997) 0.91
Isolation and partial amino acid sequence analysis of nerve growth factor from the guinea pig prostate. J Neurosci Res (1981) 0.90
K-ras activation in gastric epithelial tumors in Japanese. Cancer Lett (1991) 0.90
Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res (1998) 0.89
Differential requirement of a motif within the carboxyl-terminal domain of alpha-platelet-derived growth factor (alpha PDGF) receptor for PDGF focus forming activity chemotaxis, or growth. J Biol Chem (1995) 0.89
Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study. J Clin Oncol (1993) 0.89
Hepatocyte growth factor/scatter factor stimulates hair growth of mouse vibrissae in organ culture. J Invest Dermatol (1994) 0.88
Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling. FASEB J (2001) 0.88
Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a). Biochemistry (1978) 0.87
Laryngeal manual therapy: a preliminary study to examine its treatment effects in the management of muscle tension dysphonia. J Voice (2007) 0.87
Language screening for infants prone to otitis media. J Pediatr Psychol (1988) 0.87
Current evaluation and treatment of patients with swallowing disorders. Otolaryngol Head Neck Surg (1999) 0.86
Hepatocyte growth factor/scatter factor expressed in follicular papilla cells stimulates human hair growth in vitro. J Cell Physiol (1995) 0.86
Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate. World J Urol (1995) 0.86
Ability of the glucocorticoid modulatory element to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of glucocorticoid modulatory element and glucocorticoid response element activities. Mol Cell Endocrinol (2000) 0.85
Reliability of OperaVOX against Multidimensional Voice Program (MDVP). Clin Otolaryngol (2015) 0.85
The effect of hepatocyte growth factor/scatter factor on human hair follicle growth. J Dermatol Sci (1995) 0.85
Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries. J Cell Physiol (1997) 0.84
Keratinocyte growth factor and its receptor in the rhesus macaque placenta during the course of gestation. Placenta (1996) 0.84
A Rho-specific exchange factor Ect2 is induced from S to M phases in regenerating mouse liver. Hepatology (2000) 0.84
Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts. Endocrinology (1996) 0.84
Foreign body reaction to polymethylsiloxane gel (Bioplastique) after vocal fold augmentation. J Laryngol Otol (2008) 0.84
The anatomical basis for post-tracheotomy innominate artery rupture. Laryngoscope (1988) 0.83